Christopher Patusky sold $1.8M of United Therapeutics (UTHR)

Executed Jan 10 2025, disclosed Jan 13 2025, 3 days later.

Value, as filed

$1.8M

4,891 sh across 5 lots

Executed

Jan 10 2025

the trade date, as filed

Disclosed

Jan 13 2025

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Christopher Patusky Director profile →

Christopher Patusky (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in United Therapeutics Corporation (UTHR). The largest single filing was $1.7M of UTHR (2,910 sh × $569.00, as filed), executed Apr 24.

The name

UTHR

United Therapeutics Corporation UTHR · Healthcare · 343 filings in 24 months ticker →

Healthcare · United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Christopher Patusky in UTHR

UTHRSALE United Therapeutics Corporation $1.7M
2,910 sh × $569.00
Exec Apr 24
Filed Apr 24 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $579K
1,000 sh × $578.88
Exec Apr 17
Filed Apr 17 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $496K
1,000 sh × $495.95
Exec Dec 15 2025
Filed Dec 16 2025 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $1.4M
4,600 sh across 5 lots
Exec Mar 19 2025
Filed Mar 20 2025 · 5:30 PM ET